Stereotaxis company information, Employees & Contact Information

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025 GlobeNewswire

Stereotaxis (NYSE: STXS) sets Q3 2025 results call and webcast information Stock Titan

Surgical Robotics Leader Stereotaxis to Showcase Growth Strategy at Major Investment Conferences in NYC Stock Titan

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias GlobeNewswire

Stereotaxis to Demo GenesisX Robotic System at HRS Diagnostic and Interventional Cardiology

Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism Frontiers

Stereotaxis, Inc. Secures $12.5 Million in Registered Direct Offering to Enhance Balance Sheet and Accelerate Product Commercialization Nasdaq

Stereotaxis to Present at Upcoming Investor Conferences GlobeNewswire

Stereotaxis Synchrony System Gets European CE Mark; Applies for FDA 510(k) Certification Diagnostic and Interventional Cardiology

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter GlobeNewswire

Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework Diagnostic and Interventional Cardiology

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock GlobeNewswire

Stereotaxis Reports 2025 Second Quarter Financial Results GlobeNewswire

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025 GlobeNewswire

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 GlobeNewswire

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance GlobeNewswire

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter GlobeNewswire

Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies GlobeNewswire

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System GlobeNewswire

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter HMP Global Learning Network

Stereotaxis Announces Acceptance into NVIDIA Connect Program and Highlights at NVIDIA GTC Conference Nasdaq

Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter Diagnostic and Interventional Cardiology

Surgical Robotics Leader Stereotaxis Lands $12.5M Investment from Strategic Industry Partner Stock Titan

Stereotaxis Stock: Recurring Revenue Inflection (NYSE:STXS) Seeking Alpha

World's First Robotic HD Cardiac Mapping: Stereotaxis MAGiC Sweep Makes US Commercial Debut Stock Titan

Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025 Seeking Alpha

Revolutionary Cardiac Mapping Breakthrough: FDA Approves First Robotic High-Density EP Catheter Stock Titan

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs GlobeNewswire

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX GlobeNewswire

Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States Diagnostic and Interventional Cardiology

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms Diagnostic and Interventional Cardiology

CE Mark & 510(k) Submission: Stereotaxis Launches Synchrony with 55” 4K Display and SynX Cloud Stock Titan

Game-Changing Medical Robot Fits Under OR Table: European Hospital First to Order Stereotaxis' Compact GenesisX Stock Titan

Stereotaxis and Abbott Combine Technologies in First Integrated Procedures to Treat Arrhythmia Patients Diagnostic and Interventional Cardiology

Live Long-Distance TeleRobotic Procedures to Highlight Stereotaxis Technology at Asia Pacific Heart Rhythm Symposium Diagnostic and Interventional Cardiology

Stereotaxis Announces CE Mark Submission for Robotically Navigated Magic Ablation Catheter Diagnostic and Interventional Cardiology

Stereotaxis Secures CE Mark for Revolutionary MAGiC Cardiac Ablation Catheter Stock Titan

Industry Veterans Join Stereotaxis Commercial Leadership Team as Company Advances Robust Innovation Pipeline GlobeNewswire

Industry Veterans Join Stereotaxis Commercial Leadership Team as Company Advances Robust Innovation Pipeline Diagnostic and Interventional Cardiology

Corewell Health Grows Robotic Program to Treat Heart Rhythm Disorders with Adoption of Stereotaxis’ Genesis System Diagnostic and Interventional Cardiology

Stereotaxis Robotic Technology Reduces Incidence of Silent GlobeNewswire

Broward Health Medical Center First in Florida to Adopt Robotic Ablation Technology to Treat Arrhythmias Diagnostic and Interventional Cardiology

Stereotaxis and Microport EP Partner to Commercialize Electrophysiology Robotics in China Diagnostic and Interventional Cardiology

Stereotaxis to Report Third Quarter 2015 Financial Results on November 3, 2015 GlobeNewswire